Concord Medical (CCM) CEO discloses large indirect Class B and ADS stake

Rhea-AI Filing Summary

Concord Medical Services Holdings Ltd director and chief executive officer Yang Jianyu reported his initial ownership in a Form 3. He may be deemed the beneficial owner of 38,287,948 Class B ordinary shares held by Morgancreek Investment Holding Limited, all convertible into an equal number of Class A ordinary shares at no cost. He is also attributed 466,097 American depositary shares, each representing 30 Class A ordinary shares, indirectly held by Morgancreek.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Yang Jianyu

(Last) (First) (Middle)

SEE REMARKS

(Street)

BEIJING 100020

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Concord Medical Services Holdings Ltd [ CCM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
American depositary shares	466,097	I	By Morgancreek Investment Holding Limited(1)(4)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B ordinary shares, par value US$0.0001 per share	(3)	(3)	Class A ordinary shares, par value US$0.0001 per share	38,287,948	(3)	I	By Morgancreek Investment Holding Limited(2)(4)

Explanation of Responses:

1. Represented 466,097 American depositary shares ("ADSs"), each representing 30 Class A ordinary shares, par value US$0.0001 per share, of the Issuer (the "Class A Ordinary Shares") held by Morgancreek Investment Holding Limited ("Morgancreek"), a limited liability company organized under the laws of the British Virgin Islands.

2. Represented 38,287,948 Class B ordinary shares, par value US$0.0001 per share, of the Issuer ("Class B Ordinary Shares), held by Morgancreek.

3. The Class B Ordinary Shares are convertible at any time at the option of the holder into an equal number of Class A Ordinary Shares at no cost.

4. The Reporting Person is the sole director of Morgancreek and the Reporting Person's spouse indirectly holds 70% of the equity interests in Morgancreek. As such the Reporting Person has the power to direct Morgancreek as to the voting and disposition of the Class B Ordinary Shares and the ADSs held by Morgancreek. The Reporting Person may be deemed the beneficial owner of all the Class B Ordinary Shares and ADSs representing Class A Ordinary Shares held by Morgancreek.

Remarks:

The full street address is Room A1-A5 26/F, East Zone, Hanwei Plaza, No. 7 Guanghua Road, Chaoyang District. Exhibit 24 - Power of Attorney

	/s/ Jianyu Yang	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What insider holdings did Yang Jianyu report in Concord Medical (CCM) Form 3?

Yang Jianyu reported indirect beneficial ownership of 38,287,948 Class B ordinary shares and 466,097 American depositary shares of Concord Medical through Morgancreek Investment Holding Limited, establishing his initial disclosed equity position in the company under SEC rules.

How are the Concord Medical (CCM) American depositary shares structured in this filing?

The filing states that 466,097 American depositary shares (ADSs) each represent 30 Class A ordinary shares. These ADSs are held by Morgancreek Investment Holding Limited, and Yang Jianyu may be deemed the beneficial owner of the underlying Class A ordinary shares.

What is the relationship between Concord Medical (CCM) Class B and Class A shares in this Form 3?

The Class B ordinary shares are convertible at any time, at the holder’s option, into an equal number of Class A ordinary shares at no cost. This gives the holder flexibility to switch into Class A while maintaining the same share count.

How does Morgancreek Investment Holding Limited factor into the CCM Form 3 disclosure?

Morgancreek Investment Holding Limited holds the Class B ordinary shares and ADSs. Yang Jianyu is Morgancreek’s sole director, and his spouse indirectly holds 70% of its equity, so he may be deemed to beneficially own the securities Morgancreek holds.

Did the CCM Form 3 report any insider buying or selling activity?

No buying or selling activity is reported. The Form 3 lists holding entries only, indicating Yang Jianyu’s initial indirect beneficial ownership through Morgancreek, rather than new market transactions or changes in his position.

What level of control does Yang Jianyu have over the CCM shares held by Morgancreek?

The Form 3 notes that Yang Jianyu can direct Morgancreek’s voting and disposition of the Class B ordinary shares and ADSs. This control supports treating him as the beneficial owner of those Concord Medical securities.